Skip to main content

Fluorouracil and capecitabine - DPD deficiency

Medicines safety update

Product Information (PI) documents for fluorouracil and capecitabine are being updated to expand the existing warning and information about dihydropyrimidine dehydrogenase (DPD) deficiency. Prescribers are advised to consider a reduced starting dose where partial DPD deficiency is detected.


Related content

Help us improve the Therapeutic Goods Administration site